Literature DB >> 18458171

Selective vacuolar degeneration in dystrophin-deficient canine Purkinje fibers despite preservation of dystrophin-associated proteins with overexpression of Dp71.

Nobuyuki Urasawa1, Michiko R Wada, Noboru Machida, Katsutoshi Yuasa, Yoshiki Shimatsu, Yoshito Wakao, Shigeki Yuasa, Toshiaki Sano, Ikuya Nonaka, Akinori Nakamura, Shin'ichi Takeda.   

Abstract

BACKGROUND: Respiratory support therapy significantly improves life span in patients with Duchenne muscular dystrophy; cardiac-related fatalities, including lethal arrhythmias, then become a crucial issue. It is therefore important to more thoroughly understand cardiac involvement, especially pathology of the conduction system, in the larger Duchenne muscular dystrophy animal models such as dystrophic dogs. METHODS AND
RESULTS: When 10 dogs with canine X-linked muscular dystrophy in Japan (CXMD(J)) were examined at the age of 1 to 13 months, dystrophic changes of the ventricular myocardium were not evident; however, Purkinje fibers showed remarkable vacuolar degeneration as early as 4 months of age. The degeneration of CXMD(J) Purkinje fibers was coincident with overexpression of Dp71 at the sarcolemma and translocation of mu-calpain to the cell periphery near the sarcolemma or in the vacuoles. Immunoblotting of the microdissected fraction showed that mu-calpain-sensitive proteins such as desmin and cardiac troponin-I or -T were selectively degraded in the CXMD(J) Purkinje fibers. Utrophin was highly upregulated in the earlier stage of CXMD(J) Purkinje fibers, but the expression was dislocated when vacuolar degeneration was recognized at 4 months of age. Nevertheless, the expression of dystrophin-associated proteins alpha-, beta-, gamma-, and delta-sarcoglycans and beta-dystroglycan was well maintained at the sarcolemma of Purkinje fibers.
CONCLUSIONS: Selective vacuolar degeneration of Purkinje fibers was found in the early stages of dystrophin deficiency. Dislocation of utrophin besides upregulation of Dp71 can be involved with this pathology. The degeneration of Purkinje fibers can be associated with the distinct deep Q waves in ECG and fatal arrhythmia seen in dystrophin deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458171     DOI: 10.1161/CIRCULATIONAHA.107.739326

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.

Authors:  Deborah M Fine; Jin-Hong Shin; Yongping Yue; Dietrich Volkmann; Stacey B Leach; Bruce F Smith; Mark McIntosh; Dongsheng Duan
Journal:  Neuromuscul Disord       Date:  2011-05-13       Impact factor: 4.296

Review 2.  Dystrophin-deficient large animal models: translational research and exon skipping.

Authors:  Xinran Yu; Bo Bao; Yusuke Echigoya; Toshifumi Yokota
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

3.  Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates.

Authors:  Kenji Rowel Q Lim; Yusuke Echigoya; Tetsuya Nagata; Mutsuki Kuraoka; Masanori Kobayashi; Yoshitsugu Aoki; Terence Partridge; Rika Maruyama; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Mol Ther       Date:  2018-10-19       Impact factor: 11.454

4.  Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy.

Authors:  Hideya Mizuno; Akinori Nakamura; Yoshitsugu Aoki; Naoki Ito; Soichiro Kishi; Kazuhiro Yamamoto; Masayuki Sekiguchi; Shin'ichi Takeda; Kazuo Hashido
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

5.  AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.

Authors:  Brian Bostick; Jin-Hong Shin; Yongping Yue; Nalinda B Wasala; Yi Lai; Dongsheng Duan
Journal:  J Mol Cell Cardiol       Date:  2012-05-12       Impact factor: 5.000

Review 6.  Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications.

Authors:  Akinori Nakamura; Shin'ichi Takeda
Journal:  J Biomed Biotechnol       Date:  2011-01-05

7.  An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed.

Authors:  Bruce F Smith; Yongping Yue; Philip R Woods; Joe N Kornegay; Jin-Hong Shin; Regina R Williams; Dongsheng Duan
Journal:  Lab Invest       Date:  2010-08-16       Impact factor: 5.662

Review 8.  Progress in muscular dystrophy research with special emphasis on gene therapy.

Authors:  Hideo Sugita; Shin'ichi Takeda
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

9.  Induced pluripotent stem cells in cardiovascular medicine.

Authors:  Toru Egashira; Shinsuke Yuasa; Keiichi Fukuda
Journal:  Stem Cells Int       Date:  2011-10-02       Impact factor: 5.443

10.  Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.

Authors:  Yusuke Echigoya; Akinori Nakamura; Tetsuya Nagata; Nobuyuki Urasawa; Kenji Rowel Q Lim; Nhu Trieu; Dharminder Panesar; Mutsuki Kuraoka; Hong M Moulton; Takashi Saito; Yoshitsugu Aoki; Patrick Iversen; Peter Sazani; Ryszard Kole; Rika Maruyama; Terry Partridge; Shin'ichi Takeda; Toshifumi Yokota
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.